AbCellera Biologics Inc. ABCL Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Licensing and royalty revenue | $191K— | —— | —— | —— | $167K— | |
| Research fees | $8.12M+5.7% | $7.68M-12.9% | $8.82M+32.8% | $6.64M+63.2% | $4.07M-14.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does AbCellera Biologics Inc. break its business down?
- AbCellera Biologics Inc. (ABCL) reports total revenue by product across 2 parts — Licensing and royalty revenue and Research fees. Each is extracted from the segment footnotes and tracked over time.
- Where does AbCellera Biologics Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in AbCellera Biologics Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.